We have shown that in somatotropinomas and prolactinomas there is increased positivity of c-kit and PDGFR-β, whereas in NFPAs exhibit higher VEGF and PDGFR-α positivity. This evidence concerns the gene KIT and growth hormone-producing pituitary gland neoplasm.